The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
JohnnieW, I’m not sure anyone is saying that the Mcaps should be exactly equal. Some think IKA is more valuable. Most agree that the large disparity will/should be reduced. QS may fall, indeed it has from what $45b? Any further reductions in its sp are still likely to see them valued at many multiples of IKA.
The fact they are both in the same fields is the ultimate reasonable basis for making a comparison. How can it not be? In terms of US vs UK investor’s mentality, 12% and rising IKA shares are held by US investors. Have a look at the daily OTC volumes and various US based bb where they talk consistently about the disparity and how IKA is still under the radar.
Different strategies yes. The UK Gov’t are picking up the big ticket items for IKA. What’s not to like?
I agree. The discrepancy HAS to be “resolved”. If not soon (which it could do any day) then certainly as it becomes evident that IKA are making further progress (Stearax equipment installed, UKBIC, Stacking pouches etc) large chunks will be taken out of the gap. When it happens the sp will move & move quickly imo
Agree. Also - Extract from Ilika-Capital-Markets-Day-Presentation-Dec-2019
“BMW / Solid Power - Sulfide-based material is toxic and difficult to handle, processing equipment and package are expensive and complicated”
Secondary Market: https://www.nexexchange.com/member?securityid=103421
Absolutely right! Results matter, “progress” not so much. They seem to be making the latter but after being in charge for so long, it seems the new Chairman is responsible for it & not Mr Purdy. Also getting a bit tired of the same old speeches/presentations & the relentless & seemingly irrelevant twitter posts on how everyone is using sensors, none of which have the M250. Rant over
Completely agree with the subject heading & much of your content in post 13.58. Maybe I’m an eternal optimist but certainly by 30 April 2017 we will know what the state of play is & what sort of demand is out there. I think/hope lots. Also, I’m working off the belief that the first product launch is always the hardest & that those in the future will have the benefit of experience and the cost/time efficiencies that usually come with it. They have stated they expect the first contract to be announced this calendar year; 4 months waiting max, a relatively short period of time for an IKA investor :)
B, I take your point. My initial thoughts (based purely on hope) was that a contract would be announced 2 weeks – 2 months following the launch. Found some solace on reading the text below posted on another site: 9 July 2016 “Don't get to pessimistic all you short-termists. There are 24 potential licensees in a live pipeline, plus a semiconductor IP company (presumably ARM Holdings, although not stated). The battery was only released in April. The decision to licence/switch from existing arrangements takes time. It is not like changing dog food brand at the supermarket. There are many processes/committees/board approvals - including in-depth due-diligence - which large company's must go through before making such a change. To have such a large number of active discussions in such a short space of time is remarkable, actually. Below is an internal note from house broker Numis post the analyst briefing - ILIKA (BUY 110P) FY Results. FY16 results are in-line with expectations (revenue £0.6m, EBIT -£3.5m, net cash £3.0m) and outlook is unchanged, with a significant uplift in revenue expected in FY17E as Ilika begins to sign licences for the solid state battery. In this regard, there is an active pipeline with 24 potential licensees and conversion of 1-2 of these would be sufficient to hit forecasts. Following on from the launch of the Stereax M250 battery in April, two further products are scheduled for launch in FY17E, targeting larger capacity and ultra-miniaturised batteries. Interest has been particularly strong for miniaturised batteries which could be used in applications like smart contact lenses and medical devices. There has also been engagement with a semiconductor IP company on integration of the battery into semiconductor chips. Current market cap is £35m/$45m, which clearly offers material upside on successful commercialisation.”
Have to disagree with just about everything you’ve said. 1. The needle has moved – up 6.54% today. 2. “so please be careful.” – of what? Bizarre! 3. Still have approximately a years’ worth of cash per last calculations 4. Its greatest weakness (as you put it) lead to the development of Stereax through doing work with Toyota. Could have similar results with JM Above all, interesting that you wrote your comments today when the share price has gone up and not yesterday when the news you claim will not change anything was actually released. Atb you big fan of IKA
It’s impossible to say if it will go north from here or take a dip first. IMO north is the general direction in either scenario. Seems to be a pretty good combined team of management and scientific know-how, moving forward according to their stated plan. If that continues through to mass commercialisation with anyone of their technologies 80p or 115p shouldn’t be too significant.